← FDA Drug Approvals (Drugs@FDA)

VIGABATRIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS LIFESCIENCES · Approved 2022-01-19

Drug application

FDA Application #

ANDA215707

Application type

Abbreviated New Drug Application (Generic)

Brand name

VIGABATRIN

Generic name

VIGABATRIN

Active ingredients

VIGABATRIN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ZYDUS LIFESCIENCES

Manufacturer

Zydus Pharmaceuticals (USA) Inc.

First approval

2022-01-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown